Discouraging Non-ELISA antiphospholipid antibody assays in antiphospholipid syndrome classification may hinder clinical research
To the Editor: The new 2023 ACR/EULAR classification criteria for antiphospholipid
syndrome (APS) is a significant step forward with respect to defining a more homogeneous …
syndrome (APS) is a significant step forward with respect to defining a more homogeneous …
Towards harmonized interpretation of anticardiolipin and anti-β2-glycoprotein I antibody detection for diagnosis of antiphospholipid syndrome using defined level …
A Vandevelde, JC Gris, GW Moore, J Musiał… - Journal of Thrombosis …, 2024 - Elsevier
Background Improving harmonization of the clinical interpretation of anticardiolipin (aCL)
and anti-β2-glycoprotein I antibodies (aβ2GPI) IgG/IgM in the diagnosis of antiphospholipid …
and anti-β2-glycoprotein I antibodies (aβ2GPI) IgG/IgM in the diagnosis of antiphospholipid …